Teva Pharmaceuticals USA, Inc recalls Clonidine Transdermal System
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: use of an unapproved raw material
- Products
-
- Clonidine Transdermal System
- Where it was sold
-
Within U.S
- Units affected
- 113,943 Cartons
- About this recall
- Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch